Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Leases Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Daily Values

Growth Metrics

Others

Novavax (NVAX) Long-Term Investments: 2012-2013

Novavax's Long-Term Investments was N/A to $1.1 million in Q1 2013 from the same period last year, while for Mar 2013 it was $1.1 million, marking a year-over-year change of. This contributed to the annual value of $6.2 million for FY2012, which is N/A change from last year.
Per Novavax's latest filing, its Long-Term Investments stood at $1.1 million for Q1 2013, which was down 82.08% from $6.2 million recorded in Q4 2012.
In the past 5 years, Novavax's Long-Term Investments registered a high of $6.2 million during Q4 2012, and its lowest value of $1.1 million during Q1 2013.
For the 2-year period, Novavax's Long-Term Investments averaged around $3.7 million, with its median value being $3.7 million (2012).